Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
作者信息
Cosci Fiammetta, Fava Giovanni A
机构信息
Department of Health Sciences, University of Florence, Florence, Italy.
Clinical Pharmacopsychology Laboratory, University of Florence, Florence, Italy.
出版信息
Biomed Hub. 2021 Nov 1;6(3):118-121. doi: 10.1159/000519656. eCollection 2021 Sep-Dec.
Abstract
摘要
相似文献
1
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?为重度抑郁症开药物治疗处方：临床医生如何做出决策？
Biomed Hub. 2021 Nov 1;6(3):118-121. doi: 10.1159/000519656. eCollection 2021 Sep-Dec.
2
Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy.老年期抑郁障碍的治疗：药物治疗与心理治疗的荟萃分析比较
Am J Psychiatry. 2006 Sep;163(9):1493-501. doi: 10.1176/ajp.2006.163.9.1493.
3
Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD).初级保健的参与与酒精使用障碍（AUD）药物治疗处方的增加有关。
Addict Sci Clin Pract. 2019 May 1;14(1):19. doi: 10.1186/s13722-019-0147-3.
4
The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.《抗抑郁药治疗与心理治疗序贯治疗重性抑郁障碍：序贯模型的荟萃分析与文献综述》
Am J Psychiatry. 2016 Feb 1;173(2):128-37. doi: 10.1176/appi.ajp.2015.15040476. Epub 2015 Oct 20.
5
Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.短期动态疗法联合药物疗法治疗重度抑郁症：长期疗效
J Affect Disord. 2009 Apr;114(1-3):200-7. doi: 10.1016/j.jad.2008.07.010. Epub 2008 Aug 26.
6
Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients.有医疗保险的患者中，酒精使用障碍药物治疗的相关因素。
Drug Alcohol Depend. 2020 Sep 1;214:108174. doi: 10.1016/j.drugalcdep.2020.108174. Epub 2020 Jul 15.
7
Tachyphylaxis in unipolar major depressive disorder.单相重度抑郁症中的快速耐受性
J Clin Psychiatry. 2005 Mar;66(3):283-90. doi: 10.4088/jcp.v66n0302.
8
Maintenance pharmacotherapy for recurrent major depressive disorder: 5-year follow-up study.复发性重度抑郁症的维持性药物治疗：5年随访研究。
Br J Psychiatry. 2008 Aug;193(2):163-4. doi: 10.1192/bjp.bp.107.045708.
9
Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?认知行为疗法与药物治疗在抑郁症与焦虑症中的相对疗效：药物治疗对抑郁症是否稍好一些，而认知行为疗法对焦虑症是否稍好一些？
Depress Anxiety. 2011 Jul;28(7):560-7. doi: 10.1002/da.20829. Epub 2011 May 23.
10
[Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy].[抑郁症及共病性人格病理学的治疗：联合治疗与药物治疗]
Tijdschr Psychiatr. 2007;49(6):361-72.
本文引用的文献
1
When Anxiety and Depression Coexist: The Role of Differential Diagnosis Using Clinimetric Criteria.当焦虑和抑郁共存时：使用临床计量标准进行鉴别诊断的作用。
Psychother Psychosom. 2021;90(5):308-317. doi: 10.1159/000517518. Epub 2021 Jul 1.
2
Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder: A Systematic Review and Meta-analysis.抗抑郁药联合心理治疗与单一药物治疗对首发抑郁症的疗效比较：一项系统评价和荟萃分析
JAMA Psychiatry. 2021 Mar 1;78(3):261-269. doi: 10.1001/jamapsychiatry.2020.3650.
3
Psychotherapy in recurrent depression: efficacy, pitfalls, and recommendations.反复发作抑郁症的心理治疗：疗效、陷阱和建议。
Expert Rev Neurother. 2020 Nov;20(11):1169-1175. doi: 10.1080/14737175.2020.1804870. Epub 2020 Aug 10.
4
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications.精神药物停药后出现的急性和持续戒断综合征。
Psychother Psychosom. 2020;89(5):283-306. doi: 10.1159/000506868. Epub 2020 Apr 7.
5
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs.理解和管理抗抑郁药停药后戒断综合征。
J Clin Psychiatry. 2019 Nov 26;80(6):19com12794. doi: 10.4088/JCP.19com12794.
6
Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy.先前的抗抑郁治疗试验可能预示着在抗抑郁维持治疗期间出现抑郁复发的风险更高。
J Clin Psychopharmacol. 2019 Jul/Aug;39(4):344-350. doi: 10.1097/JCP.0000000000001049.
7
Iatrogenic Factors in Psychopathology.精神病理学中的医源性因素。
Psychother Psychosom. 2019;88(3):129-140. doi: 10.1159/000500151. Epub 2019 May 14.
8
Challenging the promotion of antidepressants for nonsevere depression.质疑非重度抑郁症抗抑郁药的推广。
Acta Psychiatr Scand. 2019 Mar;139(3):294-295. doi: 10.1111/acps.13010. Epub 2019 Feb 8.
9
The alleged lack of efficacy of antidepressants in non-severe depression: a myth debunked.抗抑郁药在非重度抑郁症中所谓的疗效不佳：一个被揭穿的神话。
Acta Psychiatr Scand. 2018 Jun;137(6):447-449. doi: 10.1111/acps.12902.
10
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.监测抗抑郁药相关不良反应在治疗重度抑郁症患者中的应用：国际共识声明。
World J Biol Psychiatry. 2018 Aug;19(5):330-348. doi: 10.1080/15622975.2017.1379609. Epub 2017 Oct 6.
Zotero 插件